Localized surface plasmon resonance (LSPR) connecting to noble metal nanoparticles is an important issue for many analytical and biological applications. Therefore, the development of microfluidic LSPR chip that allows studying biomolecular interactions becomes an essential requirement for micro total analysis systems (mTAS) integration. However, miniaturized process of the conventional surface plasmon resonance system has been faced with some limitations, especially with the usage of Kretschmann configuration in total internal reflection mode. In this study, we have tried to solve this problem by proposing a novel microfluidic LSPR chip operated with a simple collinear optical system. The poly(dimethylsiloxane) (PDMS) based microfluidic chip was fabricated by soft-lithography technique and enables to interrogate specific insulin and anti-insulin antibody reaction in real-time after immobilizing antibody on its surface. Moreover, the sensing ability of microfluidic LSPR chip was also evaluated with various glucose concentrations. The kinetic constant of insulin and anti-insulin antibody was determined and the detection limit of 100 ng/mL insulin was archived.
Introduction
Significant attention has been given to study of the biochips based on localized surface plasmon resonance (LSPR) phenomenon associated with noble metal nanoparticles in aspect of analytical chemistry and biological sensing. 1) Theoretically, LSPR is excited, when the frequencies of incident photon match the collective oscillations of the conductive electrons of metal nanoparticles, resulting in peaks in the extinction spectrum at wavelengths determined by the types of materials, size and shape of nanoparticles. 2, 3) In the LSPR based biochips, a change in interfacial refractive index (RI) upon biomolecular binding events induces a change in peak position 4) or peak magnitude, 5) thus providing an efficiently detectable optical signal. At present, LSPR based biochip using gold nanoparticles have exploited thoroughly for analyzing the molecular interactions in many applications such as antibody-antigen reaction, DNA-DNA hybridization, receptor-ligand, ligandmembrane, etc. 6) With the current advances in biochip technology, micro total analysis systems (mTAS) 7) also termed lab-on-a-chip, have received a great attractions for highly efficient, simultaneously analysis of a number of important biomolecules from proteomics to genomics. To create the overall analytical systems, several microchips which have various functions such as sample preparation, injection, separation, mixing, detection, etc are integrated into a singe device. 8) If the LPSR based chip, a surface detection tool for biomolecular interactions, is applied into the mTAS, this system has become more flexibly and widely in considerably analytical applications. Until now, a microfluidic flow cell for SPR spectroscopy was fabricated by soft lithography technique using poly(dimethylsiloxane) (PDMS). 9) This microdevice was successful to monitor the sequential layers of protein binding in real-time with rapid detection and reagent economy. However, due to the requirement Kretschmann configuration in total internal reflection mode, the planar SPR system has been faced with some drawbacks for lab-on-a-chip incorporation. In current LSPR studies, a simple collinear optical system operated in transmission geometry (without using Kretschmann configuration) has been reported. 10) Exploiting this advantage for mTAS, a microfluidic chip based on LSPR spectroscopy was proposed in this study.
Previously, our group archived the label-free detection of antigen-antibody reactions, DNA-DNA hybridizations using LSPR based nanochip. 11, 12) On the basis of the characteristics of our previous chip, in this study, we have fabricated a PDMS microfluidic LSPR chip using soft-lithography technique. For evaluating of the chip, antibody-antigen reaction was performed to detection insulin, one of the most important indicators for diabetes diagnosis. 13) After immobilizing antibody on the chip surface, real-time monitoring of insulin and anti-insulin antibody immunoreactions was studied. The LSPR responds caused by the biomolecular bindings, the dynamic range as well as the sensitivity of the chip were reported in this research. Our chip brings several advantages such as real-time detection at low experimental cost with less reagent consumption, kinetic constant determination of antigen-antibody interaction, reduction of the total analysis time, and opening the high potential for mTAS integration.
Experimental

Microfluidic LSPR chip fabrication
The approach for fabricating microfluidic LSPR chip was based on the gold-capped nanoparticles layer substrate which was developed originally in our laboratory. 11) Briefly, the silica nanoparticles (particle diameter: 100 nm, Polysciences, which were modified with amino groups on their surface by reaction with 1% (v/v) 3-aminopropyltriethoxysilane (-APTES; Shin-Etsu Chemical) solution could form esters with carboxyl groups of 4,4 0 -dithiodibutyric acid (DDA; Aldrich), thus producing a nanoparticles monolayer on the glass substrate (76 Â 26 mm 2 ). Later deposition of a thin gold layer (30 nm) to cap the silica nanoparticles could complete the fabrication process of the exciting LSPR substrate. Following these processes, a spot of LSPR substrate was created at the center of the glass slide with the diameter of 2 mm.
On the other hand, the microfluidic device (500 mm in thickness) to cover LSPR substrate was fabricated using PDMS (Dow Corning) by standard soft-lithography technique.
14) It contained two parts, microchannel and a chamber. Microchannel was created with the width of 200 mm, the height of 300 mm and the length of 30 mm. The chamber has the same diameter with LSPR substrate (2 mm) and the height of 300 mm. The inlet and outlet of the microfluidic device was made by connecting to the fluorinated ethylene propylene (FEP) tube (0:15 AE 0:05 mm i.d.) and sealing with small amounts of PDMS to prevent liquid leaks.
After washing with ethanol solution (at about 80 C) in a few seconds and cleaning with nitrogen gas, the microfluidic device was hermetically bonded to the LSPR substrate to produce a microfluidic chip for exciting LSPR respond.
Experimental setup
LSPR measurements were performed using a set of instruments: spectrophotometer (USB-2000-UV-Vis, wavelength range: 200 -1100 nm), tungsten halogen light source (LS-1, wavelength range: 360 -2000 nm), and optical fiber probe bundle (R-400-7 UV/Vis, fiber core diameter: 200 mm, wavelength range: 250 -800 nm) that were all purchased from Ocean Optics. The microfluidic LSPR chip was placed proximately to the optical fiber probe bundle surface to satisfy that the incident light was reflected upon hitting the LSPR substrate surface and coupled into a detection fiber probe and analyzed by UV-vis spectrophotometer in a wavelength range of 400 -800 nm at room temperature (RT) as shown in Fig. 1 .
Flow through the microfluidic LSPR chip was driven with the pressure from a microsyringe pump (KD Scientific) and a 500-mL volume syringe. The flow rate of 9 mL/min was set up in all experiments. The absorbance data were plotted as functions of time and recorded into a PC using OOIBase32 software (Ocean Optics).
Experimental procedure
Prior to use, the microfluidic chip based PDMS was pretreated with BSA (0.3 mg/ml) in PBS buffer in few minutes to prevent the nonspecific adsorption of protein to the hydrophobic surface of the PDMS materials.
The sensitivity of the microfluidic LSPR chip to the refractive index of solution was examined using various glucose solutions in this study. For the sample preparation, serious of glucose solutions of 2, 4, 6, and 10 mg/mL were prepared in Milli-Q water and kept at RT.
For the antibody antigen experiments, the microsyringe pump flowed PBS to the microfluidic LSPR chip through the fluorinated ethylene propylene tube. After establishing a stable LSPR signal, the different solutions, DDA, 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide (EDC; Dojindo Laboratories) and N-hydroxysuccinimide (NHS; Wako Industry) mixing, protein A (ICN Biomedicals), anti-insulin antibody (Adcam) and ethanolamine hydrochloride (Wako Industry) were injected sequentially into the fluidic stream. For all steps, the running solution was switched back to PBS at the end of each injection to rinse out any excess unbound molecules. The specific antigen-antibody binding event was detected by monitoring the changes in the peak absorbance intensity increase in real-time in the presence of various insulin (Sigma-Aldrich) concentrations (0.1, 0.5, 1, and 10 mg/mL). Four replicates of each concentration were analyzed.
Results and Discussion
Sensing evaluation of the microfluidic LSPR chip
In this report, the sensing of microfluidic LSPR chip to its surrounding RI was examined by using various glucose solutions. Previously, the sensing ability of LSPR substrates which is indicated by transducing of the surrounding RI changes into absorbance spectra was archived with some organic solvents. 4) Unfortunately, chip technology based on PDMS has some limitations with these solvents in aspects of compatibility: the swelling of PDMS in solvent, the dissolution of PDMS oligomers in solvent, and so on. 15) Overcome these problems, glucose is available for evaluating the performance of LSPR sensing. With the conversion factor of 7:12 Â 10 5 mg/dL RIU, 16) various glucose concentrations has the corresponding range of changes in RI from 2:78 Â 10 À4 to 1:39 Â 10 À3 . As a result, the peak absorbance intensity was increased as a function of the RI of glucose solutions in the range from 0 to 10 mg/mL. Our results, the increase in the peak absorbance, were in agreement with the experimental observations reported previously. 16) Figure 2 shows a linear regression line fitted with the experimental data. Quantitatively, the correlation between the regression line and the experimental data is 0.982. These results clearly show that the microfluidic LSPR chip is sensitive to the RI of the surrounding environment. Encouraged by these results, we continued to investigate the changes in the peak absorbance intensity due to the biomolecular biding events.
Performance of antibody immobilized chip surface
In this investigation, we immobilized antibody on the chip surface using the protein A as the antibody-binding substrate, resulting in ''upright'' orientation of the antibody for better interaction with the antigen.
12) The microfluidic chip was used to enable LSPR measurement of three-layer biomolecular binding assay: DDA was chemically formed to the gold substrate, protein A and anti-insulin antibodies were followed with the high affinity bindings to the preceding layer.
Initially, the microfluidic LSPR chip was set to flow the DDA solution at the flow-rate of 9 mL/min until stable absorbance intensity was archived. The increasing of peak absorbance intensity clearly indicated the binding of the thiol on the Au surface and the equilibrium time was recorded as 5 min. The formation of DDA on the gold surface would result in the exposing the carboxyl groups, thus consequently the surface could be bound to protein A after functionalizing with combination of EDC and NHS. Consequently, protein A solution was injected into the chip and a stable respond attained obviously in 10 min. The modified chip surface was then to expose to the flow of antiinsulin antibody solution for 20 min. The peak absorbance intensity increased evidently and approached a nearly plateau value after 8 min. Finally, the ethanolamine hydrochloride solution was used for blocking the remaining active ester groups, following the pushing PBS solution at the end of injection. As the results, the peak absorbance intensity was plotted continuously as a function of time corresponding to the molecular binding events on the chip surface (Fig. 3) . The absorbance spectra changes at saturation states were attained clearly: DDA, 0.005, protein A, 0.008, anti-insulin antibody, 0.009.
Detection of insulin and anti-insulin antibody reaction
on chip For label-free measurement of antigen-antibody reaction, the standard insulin solutions were introduced into chip in 20 min and the peak absorbance intensity increases were recorded as a function of time. Figure 4(a) shows the representative plots of absorbance spectra response observed for the flow of insulin at different concentrations ranging from 0.1-10 mg/mL. In the absence of insulin, the absorbance spectrum was not changed due to the biomolecular binding event was not occurred. In the presence of insulin solution, insulin binds to anti-insulin antibody on the microfluidic LSPR chip surface, and thus the peak absorb- ance intensity was increased. These results also show that the absorbance intensity increases correspond to the increasing concentration of insulin solution and the saturation value was attained after 12 minutes. The mean increases in peak absorbance intensity for binding of various insulin concentrations of 0.1, 0.5, 1, and 10 mg/mL were 0.0047, 0.0075, 0.0102, and 0.0175 (n ¼ 4) in succession, as shown in Fig. 4(b) . The results showed that the microfluidic LSPR chip could yield a limit of detection of 100 ng/mL insulin with the linear range from 0.1 to 10 mg/mL. Moreover, the kinetic constants for the process of interaction of insulin and anti-insulin antibody immobilized on surface could be determined by linear transformation of sensograms.
17) The formation rate of the complex (antigenantibody) at the time t based on the association rate constant (k a ) and disassociation rate constant (k d ) could be expressed
With the concentration of free antibody binding sites ½Ab ¼ ½Ag{Ab max À ½Ag{Ab, the following equation can be derived:
The formation of complex causes the increasing in the absorbance intensity of LSPR due to the direct proportional of refractive index on the variations in solute concentrations. The maximum absorbance intensity respond (I max ) corresponding to the saturation of the available biding sites
where
Figures 5(a) and 5(b) represent linearization data for the interaction process in coordinates of eqs. (3) and (4) . The kinetics constants calculated from these primary data were
The overall affinity constant K (k a =k d ) was thus calculated to be 2:39 Â 10 7 M À1 . These results strongly suggest that our microfluidic LSPR chip could be used to transduce the biomolecular binding at the surface into an absorbance change with a required sensitivity for biosensor applications. Using microfluidic LSPR chip, we can measure the biomolecular interactions in real-time and calculate the kinetic constants using only a single optical fiber. Additionally, a highly possible advantage of our microfluidic LSPR chip is assumed to study the cell transducing signals when this chip is connected to the cell culturing chamber. This characteristic is a great additional advantage compared to the previous LSPR systems which were performed in the air condition. Although, the current detection limit is enough for many practical applications, we trust deeply that a lower detection limit can be attained by optimization the detection chemistry such as surface density, competitive immunoassay and etc.
Conclusions
In conclusion, a PDMS microfluidic chip for LSPR spectroscopy using a simple collinear optical system was demonstrated. The chip provided a good ability to transduce the changes in the RI of glucose solutions and the biomolecular binding events into the absorbance spectra changes. The specific insulin and anti-insulin antibody reaction on the chip surface was also monitored successfully as a function of time with the limit of detection of 100 ng/ mL. The kinetic constant of antigen-antibody interaction could be calculated using this chip. As one of the most important challenges, our microfluidic LSPR chip open a high potential for mTAS integration.
